Company news
YD Bio Limited news in 2025
YD Bio Limited's news releases, calls and decks from 2025, newest first.
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
December 15, 2025
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN
December 9, 2025
YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection
December 1, 2025
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics
November 23, 2025
YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring
November 5, 2025
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
October 19, 2025
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities
October 10, 2025
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
September 29, 2025
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market
August 29, 2025